 | Alkermes plc | |||
| NMS : ALKS || Location: Ireland | ||||
$24.44-0.21 (-0.85%) |
1.31 M | 23.89 - 24.6 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 13.518 M |
| March 28, 2024 | 14.336 M |
| March 15, 2024 | 14.085 M |
| Feb. 29, 2024 | 13.020 M |
| Feb. 15, 2024 | 12.220 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | 0.52 | 0.22 | -57.99% |
| 09/30/2023 | 0.45 | 0.64 | 41.88% |
| 06/30/2023 | 0.47 | 0.55 | 16.72% |
| 03/31/2023 | -0.01 | 0.01 | 172.46% |
| 12/31/2022 | 0.05 | 0.14 | 201.08% |
ALKS Basic Data
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Shares Outstanding | 169.184M | Shares Float | 158.789M |
| Short Float | 13.518M | Market Cap | 4134.86M |
| Institution ownership | 0.00% | Insider ownership | 1.248% |
| Earnings Date | 05/01/2024 AMC | Cash Per Share | ? |
| Trailing EPS | 3.06 | Forward EPS | 2.58 |